Use of CA-125 in clinical trial evaluation of new therapeutic drugs for ovarian cancer

Saved in:
Bibliographic Details
Published in:Clinical cancer research 2004-06, Vol.10 (11), p.3919-3926
Main Authors: RUSTIN, Gordon J. S, BAST, Robert C, KELLOFF, Gary J, BARRETT, J. Carl, CARTER, Stephen K, NISEN, Perry D, SIGMAN, Caroline C, PARKINSON, David R, RUDDON, Raymond W
Format: Article
Language:English
Subjects:
Antineoplastic agents
Biological and medical sciences
Biomarkers, Tumor
CA-125 Antigen - biosynthesis
Clinical Trials as Topic
Disease-Free Survival
Drug Design
Drug Evaluation
Female
Humans
Medical sciences
Ovarian Neoplasms - drug therapy
Ovarian Neoplasms - metabolism
Ovarian Neoplasms - mortality
Pharmacology. Drug treatments
Prognosis
Research Design
Treatment Outcome
Tumors
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1078-0432
1557-3265
DOI:10.1158/1078-0432.CCR-03-0787